AcornMed (金橡医学)

As one of the few leading NGS medical service companies in the industry, both solid tumors and blood tumors, AcornMed has launched more than 30 kinds of detection products, involving early diagnosis and early screening, genetic judgment, targeting and immunotherapy of multiple cancers.

60.5
60.5
NaN
NaN
NaN
NaN
Links
Valuation
$
Funding
$ 14.15 M
$ 14.15 M
Statistics
NA

AcornMed (金橡医学)

As one of the few leading NGS medical service companies in the industry, both solid tumors and blood tumors, AcornMed has launched more than 30 kinds of detection products, involving early diagnosis and early screening, genetic judgment, targeting and immunotherapy of multiple cancers.

General Information
Merck KGaAMerck KGaAMerck KGaAMerck KGaAMerck KGaA 
View All
0and0